MindBio Therapeutics Corp. C.MBIO

CEO

[Smokey1958]

To the naysayers on MBIO CEO ....you know who you are!

* LSD has four isomers so already you're dealing with different forms
* proprietary can and does involve the process not just the end result
* add to the above that there are several ways to produce LSD using different reactants
* should "big pharma" get involved they too would have to carry out their own trials (not trails)
* as with all startups trying to determine a rational market cap is challenging at best
* the early research suggested significant psychiatric potential ...then the "street" got hold of it
* is MBIO on to something ....it seems yes, but perhaps no ....thus the investment gamble

There are numerous early stage mining companies, cancer research companies, AI companies that are valued far more than MBIO with a lot less early promise. On this meteoric alone it should be valued higher.

[Smokey1958]

I'll add another of the following to the latest naysayer on CEO: * liabilities will ALWAYS be higher than assets for a startup that has yet to make revenue. Junior mining companies have liabilities that are 10s of millions higher than their assets. Until they actually mine their only asset of "worth" (?) is their stake and/or land holding. Almost everything else that is put into